相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Incidence and risk of proteinuria associated with newly approved vascular endothelial growth factor receptor tyrosine kinase inhibitors in cancer patients: an up-to-date meta-analysis of randomized controlled trials
Wei Zhang et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2020)
Lenvatinib, a molecule with versatile application: from preclinical evidence to future development in anti-cancer treatment
Monica Capozzi et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Lenvatinib-induced renal failure: two first-time case reports and review of literature
Stefano Cavalieri et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2018)
Focal segmental glomerulosclerosis lesion associated with inhibition of tyrosine kinases by lenvatinib: a case report
Yoshitaka Furuto et al.
BMC NEPHROLOGY (2018)
Thrombotic Microangiopathy with Severe Proteinuria Induced by Lenvatinib for Radioactive Iodine-Refractory Papillary Thyroid Carcinoma
Yasuko Hyogo et al.
CASE REPORTS IN ONCOLOGY (2018)
VEGF regulates local inhibitory complement proteins in the eye and kidney
Lindsay S. Keir et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Lenvatinib for Anaplastic Thyroid Cancer
Makoto Tahara et al.
FRONTIERS IN ONCOLOGY (2017)
Safety and Pharmacokinetics of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma
Masafumi Ikeda et al.
CLINICAL CANCER RESEARCH (2016)
Lenvatinib: a potential breakthrough in advanced hepatocellular carcinoma?
Georgios Oikonomopoulos et al.
FUTURE ONCOLOGY (2016)
A Phase 2 Trial of Lenvatinib (E7080) in Advanced, Progressive, Radioiodine-Refractory, Differentiated Thyroid Cancer: A Clinical Outcomes and Biomarker Assessment
Maria E. Cabanillas et al.
CANCER (2015)
New drug toxicities in the onco-nephrology
Mark A. Perazella et al.
KIDNEY INTERNATIONAL (2015)
Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial
Robert J. Motzer et al.
LANCET ONCOLOGY (2015)
Renal effects of targeted anticancer therapies
Camillo Porta et al.
NATURE REVIEWS NEPHROLOGY (2015)
Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer
Martin Schlumberger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
PDGF-C Mediates Glomerular Capillary Repair
Peter Boor et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
VEGF inhibition and renal thrombotic microangiopathy
Vera Eremina et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
分享论文
